TY - JOUR
T1 - Ultrasound-guided injection of botulinum toxin type a for piriformis muscle syndrome
T2 - A case report and review of the literature
AU - Santamato, Andrea
AU - Micello, Maria Francesca
AU - Valeno, Giovanni
AU - Beatrice, Raffaele
AU - Cinone, Nicoletta
AU - Baricich, Alessio
AU - Picelli, Alessandro
AU - Panza, Francesco
AU - Logroscino, Giancarlo
AU - Fiore, Pietro
AU - Ranieri, Maurizio
N1 - Publisher Copyright:
© 2015 by the authors; licensee MDPI, Basel, Switzerland.
PY - 2015/8/10
Y1 - 2015/8/10
N2 - Piriformis muscle syndrome (PMS) is caused by prolonged or excessive contraction of the piriformis muscle associated with pain in the buttocks, hips, and lower limbs because of the close proximity to the sciatic nerve. Botulinum toxin type A (BoNT-A) reduces muscle hypertonia as well as muscle contracture and pain inhibiting substance P release and other inflammatory factors. BoNT-A injection technique is important considering the difficult access of the needle for deep location, the small size of the muscle, and the proximity to neurovascular structures. Ultrasound guidance is easy to use and painless and several studies describe its use during BoNT-A administration in PMS. In the present review article, we briefly updated current knowledge regarding the BoNT therapy of PMS, describing also a case report in which this syndrome was treated with an ultrasound-guided injection of incobotulinumtoxin A. Pain reduction with an increase of hip articular range of motion in this patient with PMS confirmed the effectiveness of BoNT-A injection for the management of this syndrome.
AB - Piriformis muscle syndrome (PMS) is caused by prolonged or excessive contraction of the piriformis muscle associated with pain in the buttocks, hips, and lower limbs because of the close proximity to the sciatic nerve. Botulinum toxin type A (BoNT-A) reduces muscle hypertonia as well as muscle contracture and pain inhibiting substance P release and other inflammatory factors. BoNT-A injection technique is important considering the difficult access of the needle for deep location, the small size of the muscle, and the proximity to neurovascular structures. Ultrasound guidance is easy to use and painless and several studies describe its use during BoNT-A administration in PMS. In the present review article, we briefly updated current knowledge regarding the BoNT therapy of PMS, describing also a case report in which this syndrome was treated with an ultrasound-guided injection of incobotulinumtoxin A. Pain reduction with an increase of hip articular range of motion in this patient with PMS confirmed the effectiveness of BoNT-A injection for the management of this syndrome.
KW - Botulinum toxin type A
KW - Piriformis muscle syndrome
KW - Ultrasound guide
UR - http://www.scopus.com/inward/record.url?scp=84940870159&partnerID=8YFLogxK
U2 - 10.3390/toxins7083045
DO - 10.3390/toxins7083045
M3 - Review article
SN - 2072-6651
VL - 7
SP - 3045
EP - 3056
JO - Toxins
JF - Toxins
IS - 8
ER -